Crystal structure of a complex between anthrax toxin and its host cell receptor

Nature

Volumn 430, Issue 7002, 2004, Pages 905-908

  Santelli, Eugenio ^a   Bankston, Laurie A ^a   Leppla, Stephen H ^b   Llddington, Robert C ^a  

^a BURNHAM INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BIOLOGICAL MEMBRANES; CRYSTAL STRUCTURE; PROTEINS; TUMORS;

LETHAL FACTOR (LF); OEDEMA FACTOR (EF);

CELL CULTURE;

ANTHRAX TOXIN; ANTITOXIN; BACTERIAL PROTEIN; CELL RECEPTOR; CMG2 PROTEIN; INTEGRIN; PROTEIN; PROTEIN SUBUNIT; TEM8 PROTEIN; UNCLASSIFIED DRUG;

MEDICINE;

ACIDIFICATION; ANTHRAX; ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; ENDOCYTOSIS; EXTRACELLULAR MATRIX; HOST CELL; PATHOGENESIS; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; RECEPTOR BINDING; SEQUENCE HOMOLOGY;

AMINO ACID MOTIFS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; BINDING SITES; CONSERVED SEQUENCE; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN-ION CONCENTRATION; INTEGRINS; MEMBRANE PROTEINS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PEPTIDE;

ANTHRAX; BACTERIA (MICROORGANISMS); INSERTION SEQUENCES;

EID: 3542993051     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02763     Document Type: Article

References (29)

1. Moayeri, M. & Leppla, S. H. The roles of anthrax toxin in pathogenesis. Curr. Opin. Microbiol. 7, 19-24 (2004).
2. Abrami, L., Liu, S., Cosson, P., Leppla, S. H. & Vander Goot, F. G. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol. 160, 321-328 (2003).
3. Bradley, K. A., Mogridge, J., Mourez, M., Collier, R. J. & Young, J. A. Identification of the cellular receptor for anthrax toxin. Nature 414, 225-229 (2001).
4. Scobie, H. M., Rainey, G. I., Bradley, K. A. & Young, I. A. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 100, 5170-5174 (2003).
5. Emsley, J., Knight, C. G., Farndale, R. W., Barnes, M. I. & Liddington, R. C. Structural basis of collagen recognition by integrin α2β1. Cell 101, 47-56 (2000).
6. Petosa, C., Collier, R. J., Klimpel, K. R., Leppla, S. H. & Liddington, R. C. Crystal structure of the anthrax toxin protective antigen. Nature 385, 833-838 (1997).
7. Benson, E. L., Huynh, P. D., Finkelstein, A. & Collier, R. J. Identification of residues lining the anthrax protective antigen channel. Biochemistry 37, 3941-3948 (1998).
8. Nassi, S., Collier, R. J. & Finkelstein, A. PA63 channel of anthrax toxin: an extended β-barrel. Biochemistry 41, 1445-1450 (2002).
9. Frankel, A. E., Koo, H.-K., Leppla, S. H., Duesbury, N. S. & Vande Woude, G. F. Novel protein targeted therapy of metastatic melanoma. Curr. Pharm. Des. 9, 2060-2066 (2003).
10. Lee, I.-O., Rieu, P., Arnaout, M. A. & Liddington, R. C. Crystal structure of the A-domain from the α subunit of integrin CR3 (CD11b/CD18). Cell 80, 631-635 (1995).
11. Lacy, D. B., Wigelsworth, D. I., Scobie, H. M., Young, J. A. & Collier R. J. Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: An anthrax toxin receptor. Proc. Natl Acad. Sci. USA 101, 6367-6372 (2004).
12. Wigelsworth, D. J. et al. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. J. Biol. Chem. 279, 23349-23356 (2004).
13. Shimaoka, M. et al. Structures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112, 99-111 (2003).
14. Rosovitz, M. J. et al. Alanine scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monodonal antibody. J. Biol. Chem. 278, 30936-30944 (2003).
15. Bradley, K. A. et al. Binding of anthrax toxin to its receptor is similar to α integrin-ligand interactions. J. Biol. Chem. 278, 49342-49347 (2003).
16. Mourez, M. et al. Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis. Proc. Natl Acad. Sci. USA 100, 13803-13808 (2003).
17. Miller, C. J., Elliott, J. L. & Collier, R. J. Anthrax protective antigen: prepore-to-pore conversion. Biochemistry 38, 10432-10441 (1999).
18. Petosa, C. in Crystal Structure of the Anthrax Protective Antigen. Thesis, Harvard Univ (1995).
19. Song, L. et al. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274, 1859-1866 (1996).
20. Nanda, A. & St Croix, B. Tumor endothelial markers: new targets for cancer therapy. Curr. Opin. Oncol. 16, 44-49 (2004).
21. Nanda, A. et al. TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res. 64, 817-820 (2004).
22. Liu, S., Schubert, R. L., Bugge, T. H. & Leppla, S. H. Anthrax toxin: structures, functions and tumour targeting. Expert Opin. Biol. Ther. 3, 843-853 (2003).
23. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
24. Collaborative Computational Project, No. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
25. Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjelgaard, M. Improved methods for building protein models into electron density maps and the location of error in these models. Acta Crystallogr. A 47, 110-119 (1991).
26. Morris, R. J., Perrakis, A. & Lamzin, V. S. ARP/wARP and automatic interpretation of protein electron density maps. Methods Enzymol. 374, 229-244 (2003).
27. Brunger, A. T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
28. Lee, J.-O., Bankston, L. A., Arnaout, M. A. & Liddington, R. C. Two conformations of the integrin A-domain (1-domain): a pathway for activation? Structure 3, 1333-1340 (1995).
29. Sanner, M. F., Olson, A. J. & Spehner, J. C. Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 38, 305-320 (1996).